Citation

Rallidis LS, Apostolou TS. Hellenic J. Cardiol. 2002; 43(6): 219-225.

Copyright

(Copyright © 2002, Hellenic Cardiological Society)

DOI

unavailable

PMID

unavailable

Abstract

[Abstract unavailable]

Language: en

Keywords

alanine aminotransferase; antilipemic agent; aspartate aminotransferase; atorvastatin; brain hemorrhage; carcinogenesis; cerivastatin; clinical trial; constipation; coronary artery disease; creatine kinase; cytochrome P450 3A4; drug safety; eltina; fibric acid derivative; fluindostatin; gastrointestinal symptom; gemfibrozil; Hepatoxicity; human; hydroxymethylglutaryl coenzyme A reductase inhibitor; hypercholesterolemia; indigestion; insomnia; lipoban; liver toxicity; low density lipoprotein cholesterol; low density lipoprotein receptor; mevinolin; mortality; muscle weakness; myalgia; myopathy; Myopathy; myositis; nausea; nightmare; peripheral neuropathy; placebo; pravastatin; primary prevention; rash; review; rhabdomyolysis; Safety of hypolipidaemic drugs; secondary prevention; simvastatin; Statins; suicide